Antithrombotic effects of low-molecular-weight heparin calcium (LMWH-Ca) in experimental models
Authors:
- 3 August 1999
- journal article
- research article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 33 (2) , 207-211
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Antithrombotic potencies of heparins in relation to their antifactor Xa and antithrombin activities: an experimental study in two models of thrombosis in the rabbitBritish Journal of Haematology, 1990
- Relationship between ex vivo anti-proteinase (factor Xa and thrombin) assays and in vivo anticoagulant effect of very low molecular weight heparin, CY222British Journal of Haematology, 1988
- Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4Biochemical Journal, 1984
- Discordance between the anti-Xa activity and the antithrombotic activity of an ultra-low molecular weight heparin fractionThrombosis Research, 1982
- The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbitsBlood, 1982
- Anticoagulant activities and effects on platelets of a heparin fragment with high affinity for antithrombinThrombosis Research, 1980
- Molecular weight dependency of the heparin potentiated inhibition of thrombin and activated factor X. Effect of heparin neutralization in plasmaThrombosis Research, 1979
- Anticoagulant activities of four unfractionated and fractionated heparinsThrombosis Research, 1978
- Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin III and by gel filtrationThrombosis Research, 1976
- The Partial Thromboplastin Time with Kaolin: A Simple Screening Test for First Stage Plasma Clotting Factor DeficienciesAmerican Journal of Clinical Pathology, 1961